In continuation to our communication in accordance SERI Circular No. SEBI/HO/MIRSD/DOP/CIR/P/2020/28
dated February 25, 2020 in connection with the Pledge and Re-Pledge of securities
with Clearing Member / Clearing Corporation.
B - 310,Som Datt Chambers - I,Bhikaji Cama Place ,New Delhi,Delhi-110066
Fresenius Kabi Oncology Ltd. was incorporated in the year 2003. Its today's share price is 132.45. Its current market capitalisation stands at Rs 2254.93 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6595.68 Cr and Total Income of Rs.7014.5 Cr. The company's management includes Uday Chandrashekhar Shetty, Rakesh Bhargava, Rajiv Lochan Jain, Karsten Peter Lerch, Steffen Georg Roser, Michael Schoenhofen, Nikhil Kulshreshtha, Arvind Kumar Sharma, Maria Gobbi. It is listed on the BSE with a BSE Code of 532545 , NSE with an NSE Symbol of FKONCO and ISIN of INE575G01010. It's Registered office is at B - 310,Som Datt Chambers - I,Bhikaji Cama Place New Delhi-110066, Delhi. Their Registrars are ACC Ltd. It's auditors are G Basu & Co, VMT & Co LLP
© NIRMAL BANG. All rights reserved
Designed , Developed & Content Powered by ●●●
Accord Fintech Pvt. Ltd.
Please fill in the details below
(Note - You will receive a call from our sales executive)
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document,
Do's & Don't's) in Vernacular Language :